YIELD10 BIOSCI Cash Flow - Annual (NASDAQ:YTEN)

Add to My Stocks
$2.33 $0.05 (2.19%) YTEN stock closing price Aug 21, 2017 (Closing)

The YIELD10 BIOSCI cash flow statement is one of the three reports that the company generates every quarter. Financials statements like the income statement and balance sheet show that the company has YIELD10 BIOSCI profits and YIELD10 BIOSCI debt, while the cash flow statement provides details of cash flow movments. YIELD10 BIOSCI purchased $14.7M worth of YTEN shares. The cash flow statement helps in the YIELD10 BIOSCI stock analysis by providing more information for evaluating changes in assets, liabilities and equities. YTEN increase in investments stood at a positive value of $9.75M for the latest 2016. View details of YIELD10 BIOSCI cash flows for latest & last ten financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec.2016201520142013201220112010200920082007
YIELD10 BIOSCI Net Income Cash Flow
-7.6M-23.68M-26.76M-30.5M3.63M-38.78M-38.8M-37.95M-36M-27.87M
Depreciation Depletion Amortization Cash-Flow0.51M0.26M0.5M0.92M1.29M1.5M1.64M2.73M3.73M1.45M
Net Increase (Decrease) in Assets Liabilities0.69M-1.07M-0.9M-1.47M-40.87M0.38M0.02M4.45M9.04M10.68M
Cash From (used in) Discontinued Operations-9.83M--0.84M-------
Other Adjustments Net1.52M2.62M3.48M4.4M4.21M5.16M5.13M5.01M4.83M4.83M
YIELD10 BIOSCI Net Cash from (used by) Operating Activities
-14.7M-21.86M-24.53M-26.64M-31.73M-31.73M-31.99M-25.75M-18.39M-10.9M
Increase (Decrease) in Prop Plant And Equipment-0.75M-0.61M-0.12M-0.37M-0.38M-0.89M-0.9M-1.94M-0.79M-4.66M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments--11.5M20.18M25.37M-8.01M32.31M-16.9M21.97M10.46M
Other Cash Inflow (Outflow) from Investment Activities10.5M-0.29M-0.02M0.02M--0.02M--0.09M-
YIELD10 BIOSCI Net Cash from (used by) Invesment Activities
9.75M-0.61M11.67M19.78M25.01M-8.9M31.37M-18.85M21.08M5.8M
Issuance (Purchase) of Equity Shares-14.7M25.21M0.01M0.01M49.4M2.33M29.23M0.81M2.6M
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
YIELD10 BIOSCI Net Cash from (used by) Financing Activities
-14.7M25.21M0.01M0.01M49.4M2.33M29.23M0.81M2.6M
Effect of Exchange Rate Changes on Cash-0.01M---0.02M-0.01M-0.01M-0.01M---
YIELD10 BIOSCI Net Change in Cash & Cash Equivalents
-4.96M-7.77M12.34M-6.87M-6.7M8.75M1.71M-15.38M3.5M-2.49M
Cash & Equivalents at Beginning of Year12.26M20.04M7.69M14.57M21.27M12.52M10.81M26.19M22.68M25.18M
Cash & Equivalents at Year End7.3M12.26M20.04M7.69M14.57M21.27M12.52M10.81M26.19M22.68M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Cash flow for another ticker

YIELD10 BIOSCI stock price history provides insight into historical stock price fluctuations, and YIELD10 BIOSCI stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:
  • Net Change in Cash and Cash Equivalents: YIELD10 BIOSCI cash grew YoY to $-7.6M, meaning the company is able to meet its expenditure and grow cash which will also eventually reflect in the YIELD10 BIOSCI stock price movement.
  • Cash Flow from operating activities: YIELD10 BIOSCI reported a negative operating cash flow of $-14.7M for 2016 and has seen an increase from the previous year. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: YIELD10 BIOSCI generated $10.36M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. YIELD10 BIOSCI spent $14.7M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.
.

Key Financial Ratios For YIELD10 BIOSCI Cash Flow

FCF margin
-7.59